Related Experiment Video
Updated: Mar 17, 2026

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
Published on: June 23, 2022
Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex
Anna Jeong1, Michael Wong1,2
1Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, U.S.A.
Epilepsy is a common and disabling symptom in tuberous sclerosis complex (TSC). This study found that systemic manifestations like cardiac rhabdomyomas are linked to a higher risk of epilepsy in TSC patients.
Area of Science:
- Neurology
- Genetics
- Dermatology
Background:
- Epilepsy is a significant disabling symptom in tuberous sclerosis complex (TSC).
- The association between systemic TSC manifestations and epilepsy requires further investigation.
- Understanding these links can aid in prognostication and targeted therapies for TSC-related epilepsy.
Purpose of the Study:
- To investigate the relationship between systemic disease manifestations and epilepsy in individuals with TSC.
- To identify specific TSC-related symptoms associated with an increased likelihood of epilepsy.
- To explore the potential for disease prognostication and targeted preventative therapies.
Main Methods:
- Utilized a multicenter TSC Natural History Database of 1,816 individuals.
- Employed univariate analysis to identify patient characteristics associated with epilepsy.
- Constructed logistic regression models (individual and multivariable) to assess associations, controlling for covariates.
Main Results:
- Nearly 88% of the cohort experienced epilepsy.
- Multiple systemic manifestations, including cardiac rhabdomyomas, retinal hamartomas, and renal lesions, were associated with higher epilepsy risk.
- Cardiac rhabdomyomas remained significantly associated with epilepsy in the multivariable model (OR 1.9, p=0.04).
Conclusions:
- Systemic disease manifestations in TSC are significantly associated with the presence of epilepsy.
- Cardiac rhabdomyomas are a key indicator of increased epilepsy risk in TSC.
- Identifying these markers can improve prognostication and guide the development of preventative treatments for TSC-related epilepsy.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Chronic Kidney Disease II: Clinical Manifestations
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

